Related Experiment Video
Updated: Jul 20, 2026

10:13
Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
Published on: July 31, 2017
Trifluoperazine protects brain plasma membrane Ca(2+)-ATPase from oxidative damaging
Patricia Souza dos Santos1, Dayvison Francis Saraiva, Danielly Cristiny Ferraz da Costa
1Instituto de Bioquímica Médica, CCS, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Experimental Brain Research
|September 7, 2006
Summary
Oxidative stress damages rat brain
Area of Science:
- Neuroscience
- Biochemistry
- Cell Biology
Background:
- Calcium homeostasis is crucial in the central nervous system (CNS).
- Disturbances in calcium balance and oxidative stress are linked to neurodegenerative diseases like Parkinson's and Alzheimer's.
- Plasma membrane Ca(2+)-ATPase (PMCA) and sarco-endoplasmic reticulum Ca(2+)-ATPase (SERCA) are key calcium transporters.
Purpose of the Study:
- To compare the susceptibility of rat brain PMCA and SERCA isoforms to oxidative stress.
- To investigate the protective role of trifluoperazine (TFP) against oxidative damage to these enzymes.
Main Methods:
- In vitro oxidative stress induction using Fe(2+)-ascorbate and H2O2.
- Assay of ATPase activity of PMCA and SERCA.
- Evaluation of protective effects of antioxidants like butylated hydroxytoluene (BHT), TFP, and dithiothreitol (DTT).
Main Results:
- Rat brain PMCA is highly sensitive to oxidative damage, while SERCA is resistant.
- TFP and BHT fully protect PMCA from Fe(2+)/ascorbate-induced inhibition, suggesting lipid peroxidation and cysteine damage.
- Under more severe oxidative stress (Fe(2+)/ascorbate + H2O2), TFP and BHT offer only partial protection, indicating additional damage mechanisms.
Conclusions:
- PMCA is more vulnerable to oxidative stress than SERCA in the rat brain.
- Trifluoperazine (TFP) demonstrates potential as an antioxidant to protect PMCA under specific oxidative stress conditions.
- Further research is needed to elucidate the mechanisms of PMCA damage and TFP's protective role.
Related Concept Videos
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Anticholinesterase Agents: Poisoning and Treatment
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...